Creative Planning
DERM icon

Creative Planning’s Journey Medical DERM Stock Holding History

Creative Planning’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-50,510
Closed -$389K – 4130
2025
Q4 		$389K Buy
50,510
+10
+0% +$78 ﹤0.01% 3045
2025
Q3 		$360K Buy
50,500
+17,736
+54% +$129K ﹤0.01% 3005
2025
Q2 		$235K Buy
32,764
+21,000
+179% +$145K ﹤0.01% 3099
2025
Q1 		$69.4K Hold
11,764
– – ﹤0.01% 3303
2024
Q4 		$46K Hold
11,764
– – ﹤0.01% 3260
2024
Q3 		$66.5K Hold
11,764
– – ﹤0.01% 3066
2024
Q2 		$66.3K Hold
11,764
– – ﹤0.01% 2897
2024
Q1 		$43.3K Hold
11,764
– – ﹤0.01% 2797
2023
Q4 		$67.8K Sell
11,764
-2,000
-15% -$8.91K ﹤0.01% 2621
2023
Q3 		$37.7K Buy
13,764
+2,000
+17% +$4.47K ﹤0.01% 2516
2023
Q2 		$18.7K Hold
11,764
– – ﹤0.01% 2510
2023
Q1 		$18.5K Hold
11,764
– – ﹤0.01% 2411
2022
Q4 		$22.6K Hold
11,764
– – ﹤0.01% 2308
2022
Q3 		$29K Hold
11,764
– – ﹤0.01% 2162
2022
Q2 		$44K Buy
+11,764
New +$46.5K ﹤0.01% 2069

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Creative Planning's DERM Position: Q1 2026 in Review

Creative Planning sold out of Journey Medical (DERM) in Q1 2026, closing a stake of 50,510 shares — an estimated $389K sold.

Creative Planning first reported a position in DERM in Q2 2022 and held it in 15 quarters. The position peaked at $389K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Creative Planning reported no remaining Journey Medical position as of Q1 2026 after selling out during the quarter.
  • Creative Planning sold 50,510 Journey Medical shares in Q1 2026, an estimated $389K.
  • Creative Planning first reported a position in Journey Medical in Q2 2022 and held it in 15 quarters.
  • Creative Planning's Journey Medical position peaked at $389K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.